Adcock Ingram - Public Comps and Valuation Multiples

Adcock Ingram Overview

About Adcock Ingram

Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India.

Founded

2007

HQ

Employees

2.4K+

Website

adcock.com

Sectors

Biopharmaceuticals

Financials

LTM Revenue $582M

LTM EBITDA $72.7M

EV

$624M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Adcock Ingram Financials

As of September 2025, Adcock Ingram reported last 12-month revenue of $582M and EBITDA of $72.7M.

In the same period, Adcock Ingram achieved $50.2M in LTM net income.

See Adcock Ingram valuation multiples based on analyst estimates

Adcock Ingram P&L

In the most recent fiscal year, Adcock Ingram reported revenue of $565M and EBITDA of $85.3M.

Adcock Ingram expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Adcock Ingram valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$582M	XXX	$565M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$186M	XXX	XXX	XXX
Gross Margin	n/a	XXX	33%	XXX	XXX	XXX
EBITDA	$72.7M	XXX	$85.3M	XXX	XXX	XXX
EBITDA Margin	12%	XXX	15%	XXX	XXX	XXX
EBIT	$68.1M	XXX	$66.3M	XXX	XXX	XXX
EBIT Margin	12%	XXX	12%	XXX	XXX	XXX
Net Profit	$50.2M	XXX	$49.7M	XXX	XXX	XXX
Net Margin	9%	XXX	9%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Adcock Ingram including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $582M. EBITDA for the last twelve months was $72.7M. In the most recent fiscal year, Adcock Ingram achieved $565M in revenue and $85.3M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$582M	Analyst estimates available to subscribers	$565M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$186M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	33.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$72.7M	Analyst estimates available to subscribers	$85.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	12.5% EBITDA margin	Analyst estimates available to subscribers	15.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$68.1M	Analyst estimates available to subscribers	$66.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	11.7% EBIT margin	Analyst estimates available to subscribers	11.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$50.2M	Analyst estimates available to subscribers	$49.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	8.6% net profit margin	Analyst estimates available to subscribers	8.8% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Adcock Ingram

This financial data table provides comprehensive performance metrics for Adcock Ingram, a company based in South Africa. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Adcock Ingram generated $582M in revenue over the last twelve months.
The company achieved $72.7M in EBITDA over the last twelve months.
Net income over the last twelve months reached $50.2M.

Fiscal Year Performance

In the most recent fiscal year, Adcock Ingram reported $565M in total revenue.
Fiscal year EBITDA was $85.3M.
The company maintained a gross profit margin of 33.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was 15.1%.
Net profit margin reached 8.8% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Adcock Ingram. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Adcock Ingram Stock Performance

Adcock Ingram has current market cap of ZAR 10.6B (or $616M), and EV of ZAR 10.8B (or $624M).

Market Cap Evolution

Adcock Ingram Stock Data

As of October 7, 2025, Adcock Ingram's stock price is ZAR 72 (or $4).

See Adcock Ingram trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$624M	$616M	XXX	XXX	XXX	XXX	$0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Adcock Ingram Valuation Multiples

Adcock Ingram's trades at 1.1x EV/Revenue multiple, and 7.4x EV/EBITDA.

See valuation multiples for Adcock Ingram and 15K+ public comps

Adcock Ingram Financial Valuation Multiples

As of October 7, 2025, Adcock Ingram has market cap of $616M and EV of $624M.

Equity research analysts estimate Adcock Ingram's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Adcock Ingram has a P/E ratio of 12.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$616M	XXX	$616M	XXX	XXX	XXX
EV (current)	$624M	XXX	$624M	XXX	XXX	XXX
EV/Revenue	1.1x	XXX	1.1x	XXX	XXX	XXX
EV/EBITDA	8.6x	XXX	7.4x	XXX	XXX	XXX
EV/EBIT	9.2x	XXX	9.2x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	12.3x	XXX	12.7x	XXX	XXX	XXX
EV/FCF	n/a	XXX	37.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Adcock Ingram Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Adcock Ingram Margins & Growth Rates

Adcock Ingram's last 12 month revenue growth is 5%

Adcock Ingram's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $49K for the same period.

Adcock Ingram's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Adcock Ingram's rule of X is 25% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Adcock Ingram and other 15K+ public comps

Adcock Ingram Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	5%	XXX	5%	XXX	XXX	XXX
EBITDA Margin	12%	XXX	15%	XXX	XXX	XXX
EBITDA Growth	5%	XXX	-4%	XXX	XXX	XXX
Rule of 40	20%	XXX	20%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	25%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$49K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	21%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial